Status Epilepticus: Clinical Trials

7 trials for Status Epilepticus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed. 7 Phase 2, 2 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 27Completed 7
Phase 32Completed 2
Phase 11Completed 1

Follow Status Epilepticus: new trials by email Literature Review of Status Epilepticus trials Research Report on Status Epilepticus

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Combined Ketamine and Midazolam for Generalized Convulsive Status Epilepticus
Ketamine, Midazolam, Placebo - Generalized Convulsive Status Epilepticus
Phase 2 / Phase 3CompletedSohag University1442023-03-212024-10-29
VIGABatrin in Post-anoxic STATus Epilepticus - Phase IIa
Vigabatrin Only Product - Status Epilepticus, Electrographic, Coma
Phase 2CompletedUniversity of Florida62021-09-222024-07-23
Effectiveness of Combined Levetiracetam and Midazolam in Generalized Convulsive Status Epilepticus in Children
Levetiracetam, Midazolam, Placebo - Status Epilepticus, Generalized Convulsive Status Epilepticus
Phase 2CompletedSohag University1442021-06-202022-09-21
Intravenous Ganaxolone as Adjunctive Therapy to Treat Subjects With Status Epilepticus
IV Ganaxolone active, IV Placebo, non-active - Status Epilepticus, Convulsive Status EPILEPTICUS
Phase 2CompletedMarinus Pharmaceuticals172018-02-192023-03-09
Levetiracetam Versus Sodium Valproate in Children With Refractory Generalized Convulsive Status Epilepticus
Intravenous levetiracetam, Sodium valproate - Grand Mal Status Epilepticus
Phase 2CompletedBanaras Hindu University802015-01-012016-09-30
Study to Evaluate SAGE-547 Injection as Adjunctive Therapy for the Treatment of Super-Refractory Status Epilepticus
SAGE-547 - Super-refractory Status Epilepticus
Phase 1 / Phase 2CompletedSupernus Pharmaceuticals, Inc.252014-03-212025-09-15
Efficacy and Safety Study Comparing Lorazepam and Diazepam for Children in the Emergency Department With Seizures (Status 2)
lorazepam or diazepam - Status Epilepticus
Phase 2 / Phase 3CompletedEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)2592008-02-012012-12-18

Narrower conditions

Coma (1)  ·  Epilepsy (1)  ·  Heart Arrest (1)  ·  Seizures (1)

Broader conditions

Nervous System Diseases (7)  ·  Neurologic Manifestations (7)  ·  Pathological Conditions, Signs and Symptoms (7)  ·  Signs and Symptoms (7)  ·  Seizures (6)  ·  Brain Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Consciousness Disorders (1)  ·  Heart Diseases (1)  ·  Neurobehavioral Manifestations (1)  ·  Unconsciousness (1)

Interventions

Midazolam (2)  ·  Diazepam (1)  ·  Ketamine (1)  ·  Levetiracetam (1)  ·  Lorazepam (1)  ·  Valproic Acid (1)  ·  Vigabatrin (1)  ·  brexanolone (1)

Sponsors

Sohag University (2)  ·  Banaras Hindu University (1)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)  ·  Marinus Pharmaceuticals (1)  ·  Supernus Pharmaceuticals, Inc. (1)  ·  University of Florida (1)

Countries

United States (4)  ·  Egypt (2)  ·  Canada (1)

Top investigators

Abdelrahim A Sadek, MD, PhD (2)  ·  Carolina B Maciel, MD, MSCR (1)  ·  James Chamberlain, MD (1)  ·  Maciej Gasior, MD, PhD (1)  ·  Rajniti Prasad, MD (1)  ·  Robert Lasser, MD, MBA (1)

Results publications

PMID 24756515, PMID 27993298, PMID 35067230, PMID 35748707